BRITISH AMERICAN TOBACCO WKN: 916018 ISIN: GB0002875804 Kürzel: BMT Forum: Aktien Thema: Hauptdiskussion
Outlook: – Global tobacco industry volume expected to be down c.2%. – c.1% revenue growth (at constant rates), as we navigate increased excise and VAT in Bangladesh and new tobacco regulations in Australia. – 1.5-2.5% adjusted profit from operations growth (adjusted for Canada, at constant rates)*, including an expected c.1.5% transactional FX headwind. – Performance expected to be second half weighted as we deploy our innovations throughout the year. – Net finance costs* expected to be around £1.8 billion (adjusted for Canada). – The impact of translational foreign exchange is expected to be broadly flat on full year adjusted profit from operations growth. – Operating cash flow conversion in excess of 90%, with gross capital expenditure in 2025 of approximately £650 million. – Continue to deleverage (adjusted for Canada) to our 2.0-2.5x adjusted net debt/adjusted EBITDA corridor by 2026. – Commitment to dividend growth in sterling terms and £900 million share buy-back.
Outlook: – Global tobacco industry volume expected to be down c.2%. – c.1% revenue growth (at constant rates), as we navigate increased excise and VAT in Bangladesh and new tobacco regulations in Australia. – 1.5-2.5% adjusted profit from operations growth (adjusted for Canada, at constant rates)*, including an expected c.1.5% transactional FX headwind. – Performance expected to be second half weighted as we deploy our innovations throughout the year. – Net finance costs* expected to be around £1.8 billion (adjusted for Canada). – The impact of translational foreign exchange is expected to be broadly flat on full year adjusted profit from operations growth. – Operating cash flow conversion in excess of 90%, with gross capital expenditure in 2025 of approximately £650 million. – Continue to deleverage (adjusted for Canada) to our 2.0-2.5x adjusted net debt/adjusted EBITDA corridor by 2026. – Commitment to dividend growth in sterling terms and £900 million share buy-back.
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | BRITISH AMERICAN TOBACCO Hauptdiskussion | ||
| 2 | BAT Diskussionsforum ohne ETON |
|
|
Thema | ||
|---|---|---|---|
| 1 | Beyond Meat Hauptdiskussion | +41,02 % | |
| 2 | Diginex | ±0,00 % | |
| 3 | DAX Hauptdiskussion | -0,69 % | |
| 4 | NVIDIA Hauptdiskussion | +0,01 % | |
| 5 | ALTECH CHEMICALS Hauptdiskussion | -1,83 % | |
| 6 | CUE BIOPHARM.INC. DL-,001 Hauptdiskussion | +2,86 % | |
| 7 | SILBERPREIS Hauptdiskussion | -0,82 % | |
| 8 | Security der nächsten Generation | ±0,00 % | |
| 9 | Hims & Hers Health Registered (A) Hauptdiskussion | +1,56 % | |
| 10 | MICROSTRATEGY Hauptdiskussion | +0,44 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | Beyond Meat Hauptdiskussion | +41,02 % | |
| 2 | Diginex | ±0,00 % | |
| 3 | NVIDIA Hauptdiskussion | +0,01 % | |
| 4 | ALTECH CHEMICALS Hauptdiskussion | -1,83 % | |
| 5 | CUE BIOPHARM.INC. DL-,001 Hauptdiskussion | +2,86 % | |
| 6 | Security der nächsten Generation | ±0,00 % | |
| 7 | Hims & Hers Health Registered (A) Hauptdiskussion | +1,56 % | |
| 8 | Aktuelles zu Almonty Industries | -0,21 % | |
| 9 | MICROSTRATEGY Hauptdiskussion | +0,44 % | |
| 10 | DEUTSCHE POST Hauptdiskussion | -0,12 % | Alle Diskussionen |